Literature DB >> 18704030

Impairment associated with adult ADHD.

Mark A Stein1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18704030     DOI: 10.1017/s1092852900003187

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  6 in total

1.  Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.

Authors:  Andrea Chronis-Tuscano; Mark A Stein
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

2.  Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.

Authors:  John T Mitchell; Lidia Zylowska; Scott H Kollins
Journal:  Cogn Behav Pract       Date:  2015-05

Review 3.  Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Authors:  Jose Martinez-Raga; Carlos Knecht; Nestor Szerman; María I Martinez
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

4.  How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample.

Authors:  István Bitter; Viktoria Simon; Sára Bálint; Agnes Mészáros; Pál Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-06       Impact factor: 5.270

5.  Clinical Correlates of Health-Related Quality of Life in Adults With Chronic Tic Disorder.

Authors:  David A Isaacs; Heather R Riordan; Daniel O Claassen
Journal:  Front Psychiatry       Date:  2021-03-10       Impact factor: 4.157

6.  Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder.

Authors:  Tobias Banaschewski; César Soutullo; Michel Lecendreux; Mats Johnson; Alessandro Zuddas; Paul Hodgkins; Ben Adeyi; Liza A Squires; David Coghill
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.